Christopher Meldrum
InvestorNot stated at DCVC Bio · Entrepreneur In Residence, DCVC Bio at DCVC (Data Collective) · Board director at Avicenna Biosciences
Durham, North Carolina, United States
About
Chris Meldrum works on new company creation at DCVC Bio, partnering with scientific founding teams from academia and industry to launch ventures, with a focus on therapeutic platform companies in biotechnology. He previously co-founded and served as Managing Director at Golden Pine Ventures, where he launched and ran six biotech start-ups spun out of eastern U.S. universities, and earlier was Director of Corporate Alliances at Paradigm Genetics and managed biotechnology out-licensing at Purdue University. He holds an MBA from the Carlson School of Management at the University of Minnesota and a bachelor's degree in chemistry from the University of Utah.
Invests in
Biotech
Board director at Avicenna Biosciences
Intro paths
→
In turn, Christopher can intro founders to Avicenna Biosciences's investors below.
Avicenna Biosciences's investors · 1
Experience
- Avicenna Biosciences, Inc.President & CEOcurrent2020 — present
- DCVC BioEntrepreneur In Residencecurrent2019 — presentRaleigh-Durham-Chapel Hill Area
- Alterna Therapeutics, Inc.President & CEO2016 — 2021
- Pique Therapeutics, Inc.President2005 — 2020
- Golden Pine VenturesManaging Director2004 — 2019
- Paradigm GeneticsDirector, Corporate Alliances2001 — 2004
- Paradigm GeneticsManager, Partnering & Business Strategy2000 — 2001
- Purdue UniversityLicensing Associate, Office of Technology Commercialization1998 — 2000
- University of MinnesotaMarketing Associate, Department of Patents & Technology1996 — 1998
- BioAnalytic MicroSystems, Inc.Director of Business Development (Internship)1997
- DataChem LaboratoriesChemistry Technician1993 — 1996
Skills & more
Biotechnology62Venture Capital67Licensing33Start-ups81Entrepreneurship44Financial Analysis5Executive Management6Patents10Mergers3Pharmaceutical Industry26Lifesciences23Angel Investing8
+12 more
Mergers & AcquisitionsTechnology TransferDue DiligencePrivate PlacementsAcquisitionsCrossFitImmunologyClinical TrialsDrug DevelopmentNegotiationCompetitive IntelligenceBusiness StrategyLanguages English · French · Italian
From Christopher's professional profile.
Colleagues at DCVC Bio
Aimee Villamayor
Office Manager & Executive Assistant, DCVC Bio at DCVC Bio
Carly Smith
Office Assistant, DCVC Bio at DCVC Bio
Dr. Adil Anjem
Entrepreneur In Residence, DCVC Bio at DCVC Bio
Dr. Andy May
Operating Partner, DCVC Bio at DCVC Bio
Dr. Emily Park
Principal, DCVC Bio at DCVC Bio
Dr. John Hamer
Managing Partner, DCVC Bio at DCVC Bio
Dr. Justin Kern
Partner, DCVC Bio at DCVC Bio
Dr. Kiersten Stead
Managing Partner, DCVC Bio at DCVC Bio
Frequently asked questions
- Who is Christopher Meldrum?
- Chris Meldrum works on new company creation at DCVC Bio, partnering with scientific founding teams from academia and industry to launch ventures, with a focus on therapeutic platform companies in biotechnology. He previously co-founded and served as Managing Director at Golden Pine Ventures, where he launched and ran six biotech start-ups spun out of eastern U.S. universities, and earlier was Director of Corporate Alliances at Paradigm Genetics and managed biotechnology out-licensing at Purdue University. He holds an MBA from the Carlson School of Management at the University of Minnesota and a bachelor's degree in chemistry from the University of Utah.
- Where does Christopher Meldrum work?
- Christopher Meldrum is Not stated at DCVC Bio and Board director at Avicenna Biosciences.
- What does Christopher Meldrum invest in?
- Christopher Meldrum invests in Biotech.
- Where did Christopher Meldrum go to school?
- Christopher Meldrum studied at UMN Carlson School of Management (MBA, Finance); University of Utah (Bachelor of Arts, Chemistry w/ Biochemistry Emphasis); Luiss Guido Carli University.
Same school
Also attended UMN Carlson School of Management46
Todd ChaffeeInvestor at IVP (Institutional Venture Partners)Troy ArnoldPartner, Echo Health Advisors at Echo Health VenturesEliseInvestor at Mairs & Power VCAndrew HeimGeneral Partner at Arthur VenturesNing LiVenture Partner at Foothill VenturesFelix ZhangVenture Partner at Artesian
+ 40 more
Also attended University of Utah78
Sid KrommenhoekPartner at AlbumEric AndersonPartner at Scale Venture PartnersKelly KoVice President of Technology Ventures and Innovation at Flare Capital PartnersTravis HeathAdministrative Partner & CFO at Signal Peak VenturesAidan DaoussisPrincipal at Balerion Space VenturesHelen McBrideOperating Partner at BOLD Longevity
+ 72 more
Also attended Luiss Guido Carli University57
Mariano AmbrosioInvestment Manager at P101 VenturesFriedrich von WulffenPrincipal at Burda Principal InvestmentsCarolin FunkPartner at Blue Bear Capital PartnersGianluca VitaleAssociate at PeakBridge VCBradley KopsickChief Operating Officer & Head of Cambodia/Myanmar at InsitorMelusine BliesenerImpact Investor at AENU
+ 51 more
Shared employers
Also worked at Paradigm Genetics2
Also worked at Purdue University36
Mohammed AlmeshekahFounder & General Partner at Outliers VCGaurav SantAdvisor, Director, UCLA Institute for Carbon Management at Overture ClimateDr. Mung ChiangPresident Northwestern University at NEW VISTA CAPITALCarla BrodleyInvestor at Blue Tulip VenturesAlibek DostiyarovInvestor at FEBE VenturesRouz JazayeriCo-founder at Catapult Ventures
+ 30 more
Also worked at University of Minnesota23
Jessica A. Zeaske, PhD, MBAManaging Partner, Strategic Investment at Echo Health VenturesBrett BrohlManaging Partner at Bread And Butter Ventures, LlcWill MorrisonPrincipal at DFJWilliam Tunstall-PedoeInvestor at Cambridge Innovation CapitalNicholas TanAssociate Director at Aura GroupKatherine M. BryanInvestor at Madison Dearborn Partners
+ 17 more